Minerva Surgical (UTRS) Projected to Post Earnings on Tuesday

Minerva Surgical (NASDAQ:UTRS) is expected to be announcing its results on Tuesday, November 17th. Analysts expect Minerva Surgical to post earnings of ($8.8066) per share and revenue of $12.15 million for the quarter.

Minerva Surgical Price Performance

The stock has a market cap of $1,000.00, a P/E ratio of -0.00 and a beta of 2.43. Minerva Surgical has a 12-month low of $0.00 and a 12-month high of $0.00.

About Minerva Surgical

Minerva Surgical, Inc. is a medical device company focused on women’s health. The company develops and commercializes technologies intended to diagnose and treat conditions affecting the uterus, with an emphasis on abnormal uterine bleeding, a common condition that can significantly affect quality of life. Its product portfolio includes the Minerva ES Endometrial Ablation System, which uses controlled energy to treat heavy menstrual bleeding, and the Symphion System, a hysteroscopic tissue-removal device used in procedures involving uterine fibroids and polyps.